Neuropeptide Y and sleep - 20/08/11
Corresponding author. Sleep Laboratory, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, Unit 222, Rue de Gozée 706, 6110 Montigny-le-Tilleul, Belgium. Tel.: +32 71 921459; fax: +32 71 921469.Summary |
Neuropeptide Y (NPY), a 36-amino-acid peptide from the pancreatic polypeptide family, is one of the more abundant peptides in the central nervous system. It acts as a neurohormone and as a neuromodulator. NPY is widely distributed in the brain, particularly the hypothalamus, the amygdala, the locus coeruleus and the cerebral cortex. At least six NPY receptors subtypes have been identified. NPY is involved in the regulation of several physiological functions such as food intake, hormonal release, circadian rhythms, cardiovascular disease, thermoregulation, stress response, anxiety and sleep. Sleep promoting effects of NPY as well as wakefulness effects of NPY were found in animals, depending on the site of injection as well as on the functional state of the structure. In humans, NPY was found to have hypnotic properties, possibly acting as a physiological antagonist of corticotropin-releasing hormone (CRH). In conclusion, NPY participates in sleep regulation in humans, particularly in the timing of sleep onset and may as such play a role in the integration of sleep regulation, food intake and metabolism.
Le texte complet de cet article est disponible en PDF.Keywords : NPY, CRH, Sleep regulation, Basal Forebrain (BF)
Plan
Vol 14 - N° 3
P. 161-165 - juin 2010 Retour au numéro
Article précédent
- PERIOD3, circadian phenotypes, and sleep homeostasis
- Derk-Jan Dijk, Simon N. Archer
- Sleep and memory in healthy children and adolescents – A critical review
- Marta Kopasz, Barbara Loessl, Magdolna Hornyak, Dieter Riemann, Christoph Nissen, Hannah Piosczyk, Ulrich Voderholzer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?